Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07254715
PHASE4

Effect of Itopride on Semaglutide Gastroparesis

Sponsor: Ain Shams University

View on ClinicalTrials.gov

Summary

Semaglutide delays gastric emptying and increases the risk of aspiration with anesthesia; So, the addition of prokinetics as Itopride, could enhance gastric emptying and hasten surgery. The investigator will evaluate the effect of Itopride on Semaglutide-induced gastroparesis and residual gastric contents after 8 hours of fasting by gastric ultrasound before anesthesia.

Official title: Does Itopride Improve Semaglutide Induced Gastroparesis Ultrasound Before Anesthesia? Randomized Controlled Trial

Key Details

Gender

FEMALE

Age Range

40 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2025-12

Completion Date

2026-04

Last Updated

2025-11-28

Healthy Volunteers

No

Interventions

DRUG

Itopride HCI 50 mg

Daily oral 50mg Itopride tablet TID, 1 hour before meals for 7 days

DRUG

Placebo

Daily placebo tablet TID, 1 hour before meals for 7 days

Locations (1)

faculty of medicine, Ain Shams University

Cairo, Cairo Governorate, Egypt